Skip to main content
CANbridge Pharmaceuticals Inc. logo

CANbridge Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · 1228 ISIN · KYG1821D1097 LEI · 8755009KKZM9ETBOF853 HKEX Manufacturing
Open in API
Filings indexed 191 across all filing types
Latest filing 2022-07-05 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 1228

About CANbridge Pharmaceuticals Inc.

http://www.canbridgepharma.com

CANbridge Pharmaceuticals Inc. is a global biopharmaceutical company focused on the research, development, and commercialization of transformative therapies for rare diseases and rare genetic conditions. The company leverages its foundation in China to deliver life-changing therapeutics globally. Its commercial portfolio includes approved products such as Hunterase® (a recombinant human Enzyme Replacement Therapy) and Livmarli (an oral inhibitor of the ileal bile acid transporter). CANbridge also maintains a pipeline of investigational therapies, including gene therapies, targeting high-impact indications in rare genetic diseases.

Recent filings

Filing Released Lang Actions
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles and functions, including committee memberships. It does not contain financial data, earnings, or detailed management discussion. It is a clear announcement about the company's board composition and governance structure. This fits the category of Board/Management Information (MANG). The document length is short and focused solely on board information, confirming it is not a full report or announcement of a report publication.
2022-07-05 English
APPOINTMENT AND RESIGNATION OF NON-EXECUTIVE DIRECTOR CHANGE IN COMPOSITION OF BOARD COMMITTEE
Board/Management Information Classification · 100% confidence The document is an announcement from CANbridge Pharmaceuticals Inc. regarding the appointment and resignation of a non-executive director and changes in the composition of the board committee. It details the background of the new appointee, Mr. Edward Hu, and the resignation of Mr. Xiao Le. The content focuses on changes in the company's board of directors and committee membership, with no financial data, earnings, or report attachments. The document is not a full report, financial statement, or regulatory filing but a management announcement about board changes. Therefore, it fits the category of Board/Management Information (MANG). The document length (7929 characters) supports it being a detailed announcement rather than a brief notice or report publication announcement.
2022-07-05 English
GRANT OF SHARE OPTIONS
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the grant of share options under a Post-IPO Share Option Scheme. It details the number of options granted, exercise price, vesting schedule, and other related information. There is no indication of financial statements, audit information, or management discussion of financial results. The document is a formal announcement of a share option grant, which is a capital-related event but not a new share issue or capital change like a stock split or new share issuance. It is not a report or presentation but a regulatory announcement about share options granted to eligible participants. This fits best under the category of Transaction in Own Shares (POS), which covers share repurchase or issuance-related transactions including share option grants.
2022-06-27 English
ELEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 100% confidence The document is titled 'ELEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION' for Canbridge Pharmaceuticals Inc. It contains detailed company constitutional documents including the Memorandum of Association and Articles of Association, which define the company's objects, powers, share capital, and governance structure. There is no indication of financial data, audit results, earnings, or management discussion. The document is a legal and governance document outlining the internal rules and structure of the company. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance documents, not just an announcement or summary.
2022-06-24 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 24, 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement from CANbridge Pharmaceuticals Inc. regarding the poll results of their Annual General Meeting (AGM) held on June 24, 2022. It details the voting outcomes on various resolutions including approval of audited financial statements, re-election of directors, appointment of auditors, and amendments to the company's memorandum and articles of association. The document does not contain the full AGM materials or presentations but reports the official voting results. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is 5377 characters, which is sufficient to include detailed voting results rather than a brief notice. Therefore, the correct classification is DVA with high confidence.
2022-06-24 English
REVISED ARRANGEMENTS FOR ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is an announcement regarding revised arrangements for the Annual General Meeting (AGM) of CANbridge Pharmaceuticals Inc., specifically detailing the change to a virtual AGM due to COVID-19 restrictions. It includes information on how shareholders can attend, vote, and submit questions electronically, changes to the proxy form, and logistical details for the meeting. There is no financial data, no full report, and no voting results presented. The document is clearly an announcement related to the AGM event itself, not the AGM materials or the results. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or announcements about the AGM arrangements.
2022-06-17 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.